SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001567619-16-003088
Filing Date
2016-10-21
Accepted
2016-10-21 16:21:46
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s001446x1_s3.htm S-3 515015
2 EXHIBIT 4.3 s001446x1_ex4-3.htm EX-4.3 287987
3 EXHIBIT 5.1 s001446x1_ex5-1.htm EX-5.1 32662
4 EXHIBIT 23.1 s001446x1_ex23-1.htm EX-23.1 2665
5 GRAPHIC s001446x1_ex5-1image001.jpg GRAPHIC 1711
6 GRAPHIC logo_edge.jpg GRAPHIC 47956
  Complete submission text file 0001567619-16-003088.txt   907938
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214196 | Film No.: 161946473
SIC: 2834 Pharmaceutical Preparations